Dr. Arshad brings more than 20 years of biotech and pharmaceutical experience to Qualigen Therapeutics. He is an oncologist with expertise in both early and late stage clinical development at several leading and emergent biopharmaceutical companies, including leadership roles at Becton Dickinson, Sanofi Genzyme, Humanigen, XOMA, Merck, Genentech, and Pfizer. Dr. Arshad was Global Head of Medical Affairs and Clinical Research for Becton Dickinson BioSciences in San Jose, California where he led a team of MDs and PHDs driving scientific strategy for a cutting-edge immuno-oncology focused portfolio.